Dynamin-1 is a potential mediator in Cancer-Related Cognitive Impairment
D. Q. Ng, C. Hudson, T. Nguyen, S. K. Gupta, Y. Q. Koh, M. M. Acharya, A. Chan
This study investigates the role of Dynamin-1 in cancer-related cognitive impairment using human and animal models, finding that DNM1 downregulation is associated with cognitive impairment onset.
bioRxiv · Jun 4, 2024Pathology